TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Consensus Rating of “Moderate Buy” from Analysts
TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report) has received an average rating of “Moderate Buy” from the six analysts that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month price objective among […]
More Stories
Sudan: UN chief alarmed at full-scale assault on El Fasher
The UN Secretary-General is gravely alarmed by reports of a full-scale assault on El Fasher by the Rapid Support Forces...
Lennar (NYSE:LEN) Issues Quarterly Earnings Results, Beats Estimates By $0.28 EPS
Lennar (NYSE:LEN – Get Free Report) posted its quarterly earnings results on Thursday. The construction company reported $3.90 earnings per...
Secret Service, Homeland Security Sued Over Records Related to Trump Assassination Attempt
By Jack Phillips A lawsuit was filed against the U.S. Secret Service and Department of Homeland Security (DHS) in a...
Trump Proposes Temporary 10 Percent Cap on Credit Card Interest Rates
By Andrew Moran Former President Donald Trump has proposed a 10 percent temporary cap on credit card interest rates, which...
A Particular Bacteria in Your Urine Can Help Protect Against Kidney Stones
By Rachel Ann T. Melegrito The urinary tract microbiome, also known as the urobiome, is home to various microorganisms. Researchers...
Cracker Barrel Old Country Store (NASDAQ:CBRL) Announces Earnings Results
Cracker Barrel Old Country Store (NASDAQ:CBRL – Get Free Report) released its quarterly earnings data on Thursday. The restaurant operator...